Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2026-02-23 @ 8:07 PM
Study NCT ID:
NCT01900158
Status:
COMPLETED
Last Update Posted:
2019-10-29
First Post:
2013-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Sponsor:
PCI Biotech AS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-15
First Submit QC Date:
None
Study First Post Date:
2013-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-28
Last Update Post Date:
2019-10-29
Last Update Post Date Type:
ACTUAL